Finance

Lists
TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
၉၀.၅၄ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၆, GMT-၃ ၁၅:၂၁:၃၉  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for TAKP34...
Mkt. cap
ဋေ ၅.၉၆ ထ
Avg. vol.
၃၆.၀၀
Volume
၀.၀၀
52-wk high
၁၀၂.၆၅ R$
52-wk low
၇၀.၈၀ R$
Shares outstanding
၁၆၀.၂၁ ဋေ
No. of employees
၅ သောင်း
Mkt. cap
ဋေ ၅.၉၆ ထ
Avg. vol.
၃၆.၀၀
Volume
၀.၀၀
52-wk high
၁၀၂.၆၅ R$
52-wk low
၇၀.၈၀ R$
Shares outstanding
၁၆၀.၂၁ ဋေ
No. of employees
၅ သောင်း
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၁ နာရီ
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Barchart.com
Barchart.com
·
ပြီးခဲ့သည့် ၁ နာရီ
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
FXLeaders
FXLeaders
·
ပြီးခဲ့သည့် ၄၅ မိနစ်
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၉ နာရီ
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees၄.၇ သောင်း
Founded၁၇၈၁ ဇွန် ၁၂
Headquarters-
Sector-
Websitetakeda.com
Last report
၂၀၂၆ ဇူ ၃၀
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
ဋေ ၁.၂၂ သိန်း / ဋေ ၁.၁၅ သိန်း
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၁၁ သိန်း
ဋေ ၁.၁၉ သိန်း
ဋေ ၁.၀၉ သိန်း
ဋေ ၁.၂၂ သိန်း
Cost of goods sold
ဋေ ၃.၈၀ သ
ဋေ ၄.၀၁ သ
ဋေ ၄.၅၃ သ
ဋေ ၄.၀၇ သ
Cost of revenue
ဋေ ၃.၈၀ သ
ဋေ ၄.၀၁ သ
ဋေ ၄.၅၃ သ
ဋေ ၄.၀၇ သ
Research and development expenses
ဋေ ၁.၆၁ သ
ဋေ ၁.၇၅ သ
ဋေ ၁.၈၈ သ
ဋေ ၁.၆၇ သ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၅၄ သ
ဋေ ၂.၈၃ သ
ဋေ ၂.၉၂ သ
ဋေ ၂.၈၇ သ
Operating expense
ဋေ ၅.၆၃ သ
ဋေ ၆.၆၁ သ
ဋေ ၅.၂၀ သ
ဋေ ၆.၁၃ သ
Total operating expenses
ဋေ ၉.၄၃ သ
ဋေ ၁.၀၆ သိန်း
ဋေ ၉.၇၃ သ
ဋေ ၁.၀၂ သိန်း
Operating income
ဋေ ၁.၇၀ သ
ဋေ ၁.၂၉ သ
ဋေ ၁.၂၂ သ
ဋေ ၂.၀၁ သ
Other non operating income
ဋေ ၇.၈၀ ထ
-ဋေ ၁.၉၇ သ
ဋေ ၁.၈၂ သ
-ဋေ ၂.၈၁ ထ
EBT including unusual items
ဋေ ၂.၈၂ ထ
ဋေ ၁.၃၄ သ
-ဋေ ၄.၅၅ သ
ဋေ ၁.၆၃ သ
EBT excluding unusual items
ဋေ ၁.၂၉ သ
ဋေ ၁.၁၄ သ
ဋေ ၇.၁၅ ထ
ဋေ ၁.၆၂ သ
Income tax expense
ဋေ ၃.၉၉ ထ
ဋေ ၃.၀၁ ထ
-ဋေ ၈.၆၆ ထ
ဋေ ၄.၉၅ ထ
Effective tax rate
၁၄၁.၆၄%
၂၂.၅၁%
၁၉.၀၄%
၃၀.၄၀%
Other operating expenses
ဋေ ၁.၆၁ ထ
ဋေ ၆.၇၁ ထ
-ဋေ ၆.၄၃ ထ
ဋေ ၅.၃၂ ထ
Net income
-ဋေ ၁.၁၈ ထ
ဋေ ၁.၀၄ သ
-ဋေ ၃.၆၈ သ
ဋေ ၁.၁၃ သ
Net profit margin
-၁.၀၆%
၈.၇၀%
-၃၃.၆၆%
၉.၂၈%
Earnings per share
-
-
-
-
Interest and investment income
ဋေ ၄.၃၉ ထ
ဋေ ၁.၈၁ သ
-
ဋေ ၂.၄၆ ထ
Interest expense
-ဋေ ၁.၆၁ သ
-
-ဋေ ၂.၄၀ သ
-ဋေ ၃.၅၇ ထ
Net interest expenses
-ဋေ ၁.၁၇ သ
ဋေ ၁.၈၁ သ
-ဋေ ၂.၄၀ သ
-ဋေ ၁.၁၁ ထ
Depreciation and amortization charges
-
-
-
-
EBITDA
ဋေ ၃.၅၅ သ
ဋေ ၃.၂၀ သ
ဋေ ၁.၉၃ သ
ဋေ ၃.၆၄ သ
Gain or loss from assets sale
၃၀.၃၀ ကုဋေ
၃၅.၈၀ ကုဋေ
၁၄၅.၈၀ ဋေ
-၆၀၀.၂၀ ဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ